SLC12A1 variant c.1684+1 G>A causes Bartter syndrome type 1 by promoting exon 13 skipping
Nephrology · 2024
DOI: 10.1111/nep.14390 ↗Kurz gefasst
Fallbericht in der Zeitschrift Nephrology, 2024. Verfasst von Wenke Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Henan Provincial People's Hospital, People's Hospital of Henan University, People's Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Bartter Syndrome, Exons, Solute Carrier Family 12, Member 1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Major and Key Projects Jointly Constructed by Henan Province and Ministry of Science and Technology, Scientific Research Startup Funds of Henan Provincial People's Hospital.
Abstract (Originalsprache)
Background
Bartter syndrome type 1, an autosomal recessive genetic disorder, is caused by pathogenic loss‐of‐function variants in the SLC12A1 gene. It is characterized by metabolic alkalosis and prenatal‐onset polyuria leading to polyhydramnios.
Methods
We identified pathogenic gene in a 12‐day‐old newborn boy with Bartter syndrome type 1 using whole‐exome sequencing. Sanger sequencing validated the identified variants. A minigene assay was performed to investigate the effect of a novel splice site variant on pre‐mRNA splicing.
Results
We found a compound heterozygous variants in the SLC12A1 gene, consisting of a known pathogenic missense mutation (NM_000338: c.769 G>A; p.Gly257Ser) and a novel splice site variant (c.1684+1 G>A). In silico predictions and an in vitro minigene splicing assay demonstrated that the splicing variant c.1684+1 G>A abolished a consensus splice donor site of SLC12A1 intron 13, resulting in complete exon 13 skipping, translational frameshift, and premature termination codon, ultimately leading to loss of SLC12A1 function.
Conclusion
Using a cell‐based in vitro assay, we revealed the aberrant effect of the pathogenic splicing variant SLC12A1 c.1684+1 G>A on pre‐mRNA splicing. Our findings expand the gene mutation spectrum of Bartter syndrome type 1, providing a basis for genetic diagnosis and the development of genetic medicines. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Provincial People's Hospital, People's Hospital of Henan University, People's Hospital of Zhengzhou University, Zhengzhou, China.
- National Health Commission Key Laboratory of Birth Defects Prevention, Henan Provincial Key Laboratory of Genetic Diseases and Functional Genomics, Zhengzhou, China.
ORCID-Profile: Shixiu Liao
Förderung
- Major and Key Projects Jointly Constructed by Henan Province and Ministry of Science and Technology
- Scientific Research Startup Funds of Henan Provincial People's Hospital
Zitieren
APA
Yang, W., Li, Y., Guo, Z., Ren, Y., Huang, J., Zhao, H., & Liao, S. (2024). SLC12A1 variant c.1684+1 G>A causes Bartter syndrome type 1 by promoting exon 13 skipping. Nephrology. https://doi.org/10.1111/nep.14390
Vancouver
Yang W, Li Y, Guo Z, Ren Y, Huang J, Zhao H, et al. SLC12A1 variant c.1684+1 G>A causes Bartter syndrome type 1 by promoting exon 13 skipping. Nephrology. 2024. doi:10.1111/nep.14390
BibTeX
@article{Yang2024,
author = {Yang, Wenke and Li, Yanjun and Guo, Zhenglong and Ren, Yanxin and Huang, Jianmei and Zhao, Huiru and Liao, Shixiu},
title = {SLC12A1 variant c.1684+1 G>A causes Bartter syndrome type 1 by promoting exon 13 skipping},
journal = {Nephrology},
year = {2024},
doi = {10.1111/nep.14390}
}
EUVIMED